Posted On: 10/18/2015 9:41:48 PM
Post# of 72440
Recent News and events:
http://m.marketwired.com/AdvancedSearch/Advan...4b9835a085
Cellceutix Chief Scientific Officer Dr. Krishna Menon Speaking at World Anti-Microbial Resistance Congress USA 2015
BEVERLY, MA --(Marketwired - October 15, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company"
, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, announced today D...
10/15/2015 10:04:06 AM
Cellceutix Provides Update on Its Phase 3 Preparations for ABSSSI
BEVERLY, MA --(Marketwired - October 13, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company" , a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, is pleased to ann...
10/13/2015 7:30:00 AM
Cellceutix Alerts Shareholders to National Media on Anti-Cancer Abilities of p53
BEVERLY, MA --(Marketwired - October 09, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company" , a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology and antimicrobial applications, today would like to highlight rec...
10/9/2015 9:57:43 AM
Cellceutix Retains Ashcroft Law Firm, Seeks Withdrawal of Complaint
BOSTON, MA --(Marketwired - October 02, 2015) - Cellceutix Corporation ( OTC : CTIX ), issues the following statement in connection with the recent filing of a frivolous and baseless lawsuit in New York: Cellceutix, headquartered in Beverly, Massachusetts, has retained ...
10/2/2015 6:19:17 AM
Enrollment Approximately 50 Percent Complete in Cellceutix Phase 2 Clinical Trial of Prurisol for Chronic Plaque Psoriasis
BEVERLY, MA --(Marketwired - September 30, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company" , a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology and antimicrobial applications, today announces that the Compan...
9/30/2015 9:00:28 AM
Cellceutix Announces Brilacidin Data to Be Presented by ICPD at the Joint 55th Interscience Conference on Antimicrobial Agents & Chemotherapy (ICAAC)
BEVERLY, MA --(Marketwired - September 16, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company" , a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology and antimicrobial applications, is pleased to report that resul...
9/16/2015 7:40:09 AM
http://m.marketwired.com/AdvancedSearch/Advan...4b9835a085
Cellceutix Chief Scientific Officer Dr. Krishna Menon Speaking at World Anti-Microbial Resistance Congress USA 2015
BEVERLY, MA --(Marketwired - October 15, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company"
, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, announced today D... 10/15/2015 10:04:06 AM
Cellceutix Provides Update on Its Phase 3 Preparations for ABSSSI
BEVERLY, MA --(Marketwired - October 13, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company"
, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, is pleased to ann... 10/13/2015 7:30:00 AM
Cellceutix Alerts Shareholders to National Media on Anti-Cancer Abilities of p53
BEVERLY, MA --(Marketwired - October 09, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company"
, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology and antimicrobial applications, today would like to highlight rec... 10/9/2015 9:57:43 AM
Cellceutix Retains Ashcroft Law Firm, Seeks Withdrawal of Complaint
BOSTON, MA --(Marketwired - October 02, 2015) - Cellceutix Corporation ( OTC : CTIX ), issues the following statement in connection with the recent filing of a frivolous and baseless lawsuit in New York: Cellceutix, headquartered in Beverly, Massachusetts, has retained ...
10/2/2015 6:19:17 AM
Enrollment Approximately 50 Percent Complete in Cellceutix Phase 2 Clinical Trial of Prurisol for Chronic Plaque Psoriasis
BEVERLY, MA --(Marketwired - September 30, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company"
, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology and antimicrobial applications, today announces that the Compan... 9/30/2015 9:00:28 AM
Cellceutix Announces Brilacidin Data to Be Presented by ICPD at the Joint 55th Interscience Conference on Antimicrobial Agents & Chemotherapy (ICAAC)
BEVERLY, MA --(Marketwired - September 16, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company"
, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology and antimicrobial applications, is pleased to report that resul... 9/16/2015 7:40:09 AM
(0)
(0)
If you try to defend yourself against lies of the board moderators your post will be deleted. Just like the board they claim to be better than!!! Watch who you trust especially the "long term investors" that support the real attackers!
Scroll down for more posts ▼
